Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2023 Apr 14;18(4):e0284181. doi: 10.1371/journal.pone.0284181

Comparison of femtosecond laser-assisted cataract surgery and conventional phacoemulsification on corneal impact: A meta-analysis and systematic review

Hanle Wang 1,#, Xinyi Chen 1,#, Jingjie Xu 1,#, Ke Yao 1,¤,*
Editor: Andrzej Grzybowski2
PMCID: PMC10104330  PMID: 37058458

Abstract

This meta-analysis aims to compare corneal injuries and function after femtosecond laser-assisted cataract surgery (FLACS) and conventional phacoemulsification surgery (CPS). A comprehensive literature search of PubMed, EMBASE, and the Cochrane Controlled Trials Register was conducted to identify randomized controlled trials (RCT) and high-quality prospective comparative cohort studies comparing FLACS with CPS. Endothelial cell loss percentage (ECL%), central corneal thickness (CCT), endothelial cell density (ECD), endothelial cell loss (ECL), percentage of the hexagonal cell (6A), and coefficient of variance (CoV) were used as an indicator of corneal injury and function. Totally 42 trials (23 RCTs and 19 prospective cohort studies), including 3916 eyes, underwent FLACS, and a total of 3736 eyes underwent CPS. ECL% is significantly lower in the FLACS group at 1–3 days (P = 0.005), 1 week (P = 0.004), 1 month (P<0.0001), 3 months (P = 0.001), and 6 months (P = 0.004) after surgery compared to CPS. ECD and ECL appeared no statistically significant difference between the two groups, except for the significant reduction of ECD at 3 months in the CPS group (P = 0.002). CCT was significantly lower in the FLACS group at 1 week (P = 0.05) and 1 month (P = 0.002) early postoperatively. While at 1–3 days (P = 0.50), 3 months (P = 0.18), and 6 months (P = 0.11), there was no difference between the FLACS group and the CPS group. No significant difference was found in the percentage of hexagonal cells and the coefficient of variance. FLACS, compared with CPS, reduces corneal injury in the early postoperative period. Corneal edema recovered faster in the FLACS group in the early postoperative period. In addition, FLACS may be a better option for patients with corneal dysfunction.

Introduction

Cataract is one of the most common eye diseases and the major cause of vision loss worldwide [1]. Surgically removing the opacity lens and replacing it with an intraocular lens is currently the only treatment for cataracts [2]. Since its invention in the 1960s, phacoemulsification has continued to improve and remained the best therapy for cataracts [3]. Femtoseconds were first applied to promote the key steps of phacoemulsification in 2008 [4], such as corneal incision, lens fragmentation, and anterior capsulotomy [5]. Ever since the discussion on the comparison of femtosecond-laser assisted cataract surgery (FLACS) with conventional phacoemulsification surgery (CPS) has never ceased. Many studies these years have suggested the optimization of FLACS for cataract surgery, including enhancing the circularity of capsulotomy [6], reducing the effective phacoemulsification time (EPT) [7], and providing better IOL placement [8].

The transparency and barrier function of the cornea is mainly sustained by the corneal endothelium [9], composed of a single layer of the endothelial cell. The corneal endothelium has no regenerative capacity [10]. Once suffering from an injury, endothelial cells cannot proliferate [11], and the loss of endothelial cells is irreversible. The healing procedures occurred as the remaining surrounding endothelial cells enlarged and migrated to cover the damaged area [12]. As a result, the endothelial cells will increase in size and alter in shape from hexagonal to pleomorphic [13]. This leads to a change in the percentage of hexagonal cells (6A) and coefficient of variance (CoV), which illustrate the function of the residual endothelial cells. During cataract surgery procedures, phacoemulsification may increase the risk of endothelial cell loss [9]. It has long been shown that phacoemulsification results in approximately 4%-25% of endothelial cell loss [14, 15]. The negative effect of phaco cataract surgery on endothelium is multifactorial and largely due to thermal [16] and mechanical injury [17]. It has been proven to be associated with surgical instruments, phacoemulsification time, ultrasound energy, and contact with lens fragments during surgery [1719]. Since femtosecond lasers are thought to modify the surgery procedure and lessen the usage of ultrasound, the effect of this technique on the endothelium is of concern.

The corneal indicators used in previous meta-studies were inadequate, and the included articles were not rigorous enough. A recently published meta-analysis selected endothelial cell loss (ECL) and central corneal thickness (CCT) as indicators to evaluate corneal damage. Kolb, et al., in the meta-analysis, noted a significant ECL decline in the FLACS group 1–3 months postoperatively, while there was no significant difference within 1 week and over 6 months. CCT was significantly higher in the CPS group in the early time. Later in the 6 months, the difference decrease [20]. It was worth mentioning that this paper not only included prospective but also retrospective studies, which are not as reliable as prospective studies and may lead to greater bias. In contrast, Chen et al. proposed in 2021 [21] that ECL was consistently significantly lower than CPS in the FLACS group in the first week after surgery. The study analyzed RCTs only, but there were multiple mistakes in the inclusion of the article. So, we supposed it is not credible enough. Besides ECL and CCT, there are other corneal indicators. As early as 2016, Chen et al. [22] used the endothelial cell loss rate (ECL%) to measure the damage to the corneal endothelium and concluded that the difference persists after surgery from 1 week to 3 months. ECL% is the ratio of the number of endothelial cells loss to preoperative endothelial cells, which eliminates the difference from baseline and therefore may be more statistically significant. However, the sample size was small at the time, and new related studies have been published in recent years. In addition, the morphology of the remaining corneal endothelial cells was also of our interest. It is represented by 6A and CoV, indicating the function of the residual endothelial cells. Corneal injury is an important effect of cataract surgery and is closely related to postoperative visual quality. Former studies had only discussed 1–2 corneal indicators. In our study, a variety of corneal indicators were selected to comprehensively evaluate the postoperative corneal condition. This meta-analysis aimed to compare corneal impact and function after FLACS and CPS to provide a reference for clinical application.

Materials and methods

Search strategy and inclusion criteria

The study followed the PRISMA guidelines (Preferred Reporting Item for Systematic Reviews and Meta-Analysis). PubMed, EMBASE, and Cochrane Library were searched by keywords: “femtosecond” OR “Femtolaser” AND “cataract” in full text. Complete and published clinical prospective trials comparing FLACS and CPS up to date December 31, 2021, were included. Reviews, conference abstracts, case reports, letters, correspondence articles, and editorials were excluded. The researches that combined with other ophthalmic surgery were excluded. Involved studies should meet the criteria as follow: 1) prospective randomized control trials or high-quality comparative cohort studies; 2) published in English or Chinese; 3) compared clinical indicators of patients undergoing simple cataract surgery with and without femtosecond laser assistant; 4) contains at least one indicator of ECD, ECL, ECL%, CCT, CoV, 6A.

Screening process

Studies screening were carried out by two authors (HL. W and JJ. X) independently. Titles and abstracts were read to screen for qualified studies, and full-text reading was performed when necessary to determine eligibility for inclusion criteria. Articles in disagreement were confirmed by a third author (XY. C) after discussion.

Quality assessment

The cohort studies were assessed by Newcastle-Ottawa Scale (NOS) [23]. The NOS is an 8-stars scale based on patient selection (four stars), comparability (one star), and outcomes (three stars). Cochrane Collaboration’s tool for risk of bias [24] was applied to evaluate the quality of included RCTs by two independent authors (HL. W, JJ. X), which had random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective reporting, and other biases.

Data extraction and outcome measurements

A standard data form was used in the extraction process, including the basic information such as title, authors, years, experimental design, sample size, clinical indicators, etc. All the disagreements were discussed and solved before data analysis and all of the data was double-checked by a second reviewer. Corneal endothelium-related clinical indicators at different postoperative time points were recorded with mean and standard deviation. When standard deviation was not reported, data were ruled out. Data expressed as medians and quartiles were converted to mean and standard deviation by Luo’s formula [25]. Data containing subgroups in FLACS or CPS were combined.

Data analysis

RevMan software (version 5.4; Cochrane Collaboration, Oxford, United Kingdom) was used in statistical analyses. The corneal indicators were recorded in continuous data presented by weighted mean differences (WMDs) with 95% CIs. Statistical heterogeneity was calculated using the chi-square test and I2 statistics, with I2 measures more than 50% being attributed to strong heterogeneity. When heterogeneity was demonstrated, random-effects models were used, otherwise fixed-effect models. It was regarded as a statistically significant difference between FLACS and CPS when the P value was less than 0.05. Sensitivity analysis assessed how the results would have changed if a single study had been omitted by a single-study deletion analysis.

Results

Literature research and trails characteristics

A total of 3281 studies were identified originally. One thousand six hundred ten duplicates were discarded. One thousand six hundred seventy-one left studies were screened by title and abstract. A full-text examination was conducted when necessary. After excluding all research that did not meet the criteria, 42 [2667] trials remained (Fig 1). Of the included studies, 23 were RCTs, and 19 were comparative cohort studies. Totally 3916 eyes underwent FLACS, and 3736 eyes underwent CPS. Characteristics of all the trials are recorded in Table 1. The quality assessment of RCTs is presented in S1 and S2 Figs, while that of the comparative cohort is in S1 Table.

Fig 1. Flow diagram for identification of relevant studies on the corneal impact of FLACS and CPS.

Fig 1

Table 1. Characteristics of the included studies.

author year study design FLACS platform country age (mean±sd) sex (male: female) no. of eye follow-up
FLACS CPS FLACS CPS FLACS CPS
Abell 2014 cohort Catalys Australia 72.4±10.1 72.6±9.8 135:270 NA 405 215 6m
Abell 2013 cohort Catalys Australia 72.8±10.5 71.8±10.8 69:81 23:28 150 51 3w
Al-Mohtaseb 2017 cohort LenSx&catalys USA 66.69±8.64 69.51±8.13 26:34 29:31 60 60 1m
Bascaran 2018 RCT Victus Spain 70.44±6.86 36:56 92 92 6m
Cavallini 2019 cohort LDV Z8 Italy 75.45±7.88 75.06±9.32 19:30 16:41 80 80 3m
Chee 2021 RCT Victus Singapore 72.3±9.5 75.8±8.0 24:21 27:21 45 48 1m
Chen 2017 cohort LenSx China 68.38±8.45 70.27±8.53 18:29 21:27 47 48 3m
Chlasta-Twardzik 2019 RCT LDV Z8 Pland 79.08±5.51 74.59±8.10 6:20 18:43 26 61 6m
Conrad-Hengerer 2013 RCT Catalys Germany 70.9 27:46 73 73 3m
Day 2021 RCT LDV Z8 UK 68±10 48:52 392 393 12m
Day 2020 RCT LDV Z8 UK 68±10 68±10 182:210 192:201 392 393 3m
Day a 2020 RCT LDV Z8 UK NA NA NA NA 292 311 12m
Duan 2017 cohort LenSx China NA NA NA NA 74 74 3m
Dzhaber 2020 RCT LenSx USA 68.3±9.1 NA NA 67 67 3m
Fan 2018 RCT LenSx China 66.1±9.2 63.9±12.5 3:7 2:6 16 15 12m
Gao 2018 cohort NA China 66.32±6.12 65.12±7.15 28:31 25:22 59 47 3m
Hansen 2020 RCT LenSx USA 68.7±8.5 69.0±14.1 27:44 25:39 64 71 3m
Kanellopoulos 2016 cohort LenSx Greece 67.3±11.99 69.92±11.73 27:40 29:37 67 66 12m
Kelkar 2020 cohort Catalys India 64.5±9.7 65.4±8.4 56:33 57:41 89 98 6m
Khan 2017 RCT LenSX Pakistan NA NA 23:25 25 25 1m
Krarup 2019 RCT LensAR Denmark NA NA 52:56 81 81 6m
Krarup 2021 RCT LensAR Denmark 75 17:17 31 31 6m
Krarup 2014 cohort LensAR Denmark NA NA NA NA 47 47 3m
Liu 2016 cohort NA China 50.1±3.3 49.6±2.6 15:6 14:7 21 21 12m
Liu 2021 RCT LDV Z8 Singapore 69.5±6.9 48:37 78 78 12m
Mencucci 2020 cohort LenSx Italy 73.9±7.7 74.5±5.8 NA NA 20 20 6m
Mursch-Edlmayr 2017 RCT Victus Germany 72±6 31:19 50 50 6m
Niu 2018 cohort LenSx China 67.12±5.64 66.39±5.23 32:38 35:47 107 126 3m
Oka 2021 RCT LenSx Japan 73.4±6.5 20:33 53 53 7m
Pisciotta 2018 cohort LDV Z8 Italy 74.07±8.48 75.72±9.16 10:20 8:22 30 30 3m
Ranjini 2017 cohort LenSx India NA NA NA NA 55 55 1m
Reddy 2021 cohort Catalys India 59.5±9.5 58.25±10.1 11:9 22:18 20 40 5w
Roberts 2019 RCT LenSx UK 69.9±10.9 70.5±9.8 100:100 82:118 200 200 1m
Schargus 2015 RCT Catalys Germany 71.8 15:22 37 37 6m
Schroeter 2021 RCT LenSx Switzerland 70.5±8.3 69.6±8.1 31:34 27:38 65 65 3m
Shi 2020 RCT LenSx China 61.09±10.87 144:134 150 150 3m
Takacs 2012 RCT LenSx Hungary 65.81±12.42 66.93±10.99 10:28 15:23 38 38 1m
Vasavada 2019 RCT LenSx India 67.21±11.11 63.70±11.84 NA NA 91 91 6m
Wu 2017 RCT NA China 62.9±4.8 61.7±5.2 NA NA 85 105 3m
Yang 2019 cohort LenSx China 60.51±3.41 61.43±3.46 25:22 24:23 47 47 3m
Yu 2015 cohort LensAR China 62.3±11.6 56.5±16.6 NA NA 25 29 3m
Yu 2016 cohort LenSx China 69.66±9.27 72.74±8.83 33:37 23:31 70 54 6m

Endothelial cell loss rate (ECL%)

Fifteen studies reported postoperative ECL%. FLACS group demonstrated significantly lower ECL% at 1–3 days (WMD: -3.95, 95%CI: -6.70, -1.21, P = 0.005), 1 week (WMD: -3.09, 95%CI: -5.19, -0.98, P = 0.004), 1 month (WMD: -3.14, 95%CI: -4.17, -1.57, P<0.0001), 3 months (WMD: -4.72, 95%CI: -7.62, -1.82, P = 0.001) and 6 months (WMD: -1.60, 95%CI: -2.70, -0.50, P = 0.004) postoperatively (Fig 2).

Fig 2. Forest plot of postoperative ECL% between FLACS and CPS at A. 1–3 days, B. 1 week, C. 1 month, D. 3 months, and E. 6 months.

Fig 2

Endothelial cell density (ECD) and Endothelial cell loss (ECL)

There was no significant difference in ECD at 1–3 days (WMD:-12.40, 95%CI:-109.56, 84.76, P = 0.80), 1 week (WMD:10.58, 95%CI:-64.10, 85.26, P = 0.78), 1 month (WMD:21.14, 95%CI:-77.01, 119.29, P = 0.67), 6 months (WMD:-1.23, 95%CI:-68.27, 65.81, P = 0.97) and 12 months (WMD:6.80, 95%CI:-52.86, 66.47, P = 0.82) after surgery between two groups, and significant difference at 3 months (WMD: 84.49, 95%CI:31.25, 137.73, P = 0.002, Fig 3).

Fig 3. Forest plot of postoperative ECD between FLACS and CPS at A. 1–3 days, B. 1 week, C. 1 month, D. 3 months, E. 6 months, and F. 12 months.

Fig 3

Similarly, there was no significant difference in ECL at 1–3 days (WMD: 50.95, 95%CI: -24.92, 126.82, P = 0.19), 15–40 days (WMD: 11.49, 95%CI: -67.40, 90.38, P = 0.78), 2–3 months (WMD:2.81, 95%CI: -32.61, 38.23, P = 0.88), and 6 months (WMD: -19.72, 95%CI: -85.63, 46.19, P = 0.56) after surgery between two groups (Fig 4).

Fig 4. Forest plot of postoperative ECL between FLACS and CPS at A. 1–3 days, B. 15–40 days, C. 2–3 months, and D. 6 months.

Fig 4

Central corneal thickness (CCT)

Fifteen studies reported postoperative CCT. No statistically significant difference was found between FLACS and CPS at 1–3 days (WMD: -3.98, 95%CI: -15.61, 7.64, P = 0.50) after surgery. Significantly lower CCT was observed in FLACS compared to CPS at 1 week (WMD: -6.17, 95%CI: -12.29, -0.06, P = 0.05) and 1 month (WMD: -6.86, 95%CI: -10.15, -2.04, P = 0.002). Whereas, later at 3 months (WMD: -4.99, 95%CI: -12.28, 2.30, P = 0.18) and 6 months (WMD: -3.44, 95%CI: -7.70, -0.82, P = 0.11), there was no statistically significant difference between two groups (Fig 5).

Fig 5. Forest plot of postoperative CCT between FLACS and CPS at A. 1–3 days, B. 1 week, C. 1 month, D. 3 months, and E. 6 months.

Fig 5

Percentage of hexagonal cells (6A)

As was reported by seven researches, no significant difference was found between FLACS and CPS group at 1 month (WMD: -0.36, 95%CI: -3.04, 2.32, P = 0.79), 3 months (WMD: 0.25, 95%CI: -1.42, 1.92, P = 0.77) and 6 months (WMD: -0.58, 95%CI: -1.79, -0.62, P = 0.34, Fig 6).

Fig 6. Forest plot of postoperative 6A between FLACS and CPS at A. 1 month, B. 3 months, and C. 6 months.

Fig 6

Coefficient of variance (CoV)

Five researches reported CoV were enrolled. No significant difference was found between the two groups at 1 month (WMD: -0.76, 95%CI: -1.99, 0.48, P = 0.23), 3 months (WMD: 0.47, 95%CI: -0.78, 1.73, P = 0.46) and 6 months (WMD: 0.35, 95%CI: -0.64, 1.34, P = 0.48, Fig 7).

Fig 7. Forest plot of postoperative 6A between FLACS and CPS at A. 1 month, B. 3 months, and C. 6 months.

Fig 7

Discussion

This meta-analysis study showed the impact of FLACS on postoperative corneal endothelial injury compared to CPS. FLACS reduced ECL% significantly at each time point postoperatively. And CCT favored FLACS at 1 week and 1 month early after surgery.

The ECL% of the FLACS group was significantly lower than that of the CPS group at each time point during 6 months postoperatively, indicating that FLACS has reduces the injury of corneal endothelial cells. This was consistent with previously published meta-analysis [22]. Cataract surgical injury may result in a decrease in corneal endothelial cells, thus affecting the function of the cornea, and leading to corneal edema. Several factors had been reported to be involved in endothelial cell loss, such as ultrasound energy, phacoemulsification time, irrigation time, and usage of balanced salt solution during operation [6870]. In FLACS, the nucleus of the lens is pre-fragmented by a femtosecond laser instead of manipulation. This allows less application of ultrasound energy and irrigating solution during cataract surgery [29], thereby reducing its damage to endothelial cells. As was reported by Abell [27] and Oshika [71], the effect of FLACS may be due to the lower requirement of effective phacoemulsification time (EPT), ultrasound energy, and irrigation fluid compared to CPS.

Lacking regenerative ability, the total amount of cells was no longer compensated after endothelial cell loss. Instead, migration and enlargement of residual cells occur as a corneal repairing procedure [9]. The remaining cells migrate to the injured area, resulting in a gradual increase in endothelial cell density when measuring at the center of the cornea [12]. This process takes months [72], therefore, lower ECL% on the first day after surgery indicated less damage to the corneal endothelium in the FLACS group. The long-term follow-up (3 months, 6 months) in the general population subgroup (S3 Fig) showed no significant difference between the two groups. It meant that the corneal endothelium can be repaired to a similar level in the FLACS and CPS groups. And the low ECL% in the FLACS group at 1 week and 1 month after surgery indicated that the corneal endothelial repair was faster in the FLACS group.

Differences in ECL% at 3 and 6 months after surgery proposed a persistent effect of FLACS and CPS on the cornea, but we found that the main impact may come from studies targeted to a specific population. Subgroup analysis of the general population revealed that ECL% at 1–3 days, 1 week, and 1 month in the FLACS group was still significantly lower than the CPS group, while no significant difference was found at 3 months and 6 months after surgery. Fuch’s syndrome or hard nuclear patients were not included in the subgroup. This result suggested that differences in ECL% in long-term follow-up are mainly caused by special populations. Fuchs’ endothelial corneal dystrophy patients were in a state of corneal decompensation preoperatively, with extremely low basal endothelial cell count [73]. In Fan’s study, the ECL% remained a significant difference until the endpoint of follow-up (12 months) [39]. And the mean ECL% in the CPS group (32.2% at 12 months) was also much higher than 4%-25%, which was previously reported in the general population [15]. Additionally, patients with hard nuclear may suffer higher ultrasound energy and prolonged phacoemulsification time to manifest the dens cataract; thus, intraoperative endothelial cells injury was even more severe [32]. In the general population, the ECL% was similar in the long-term follow-up in FLACS and CPS groups. It implied that the long-term effect of FLACS and CPS are comparable. As for the population with dysfunctional cornea, injury caused by surgery will persist [39]. Thus, we strongly recommend that FLACS may be the superior option for corneal dysfunction and hard nuclear patients.

Contrary to previously published meta-analysis [20, 21], ECD and ECL did not show significant differences across periods. It was possibly because that the absolute value of endothelial cells may be affected by the baseline level (preoperative ECD), while the ECL% can rule out the influence. ECL% is the percentage of endothelial cell loss in the preoperative endothelial cell density, calculated by the formula: ECL% = ((preoperative ECD- postoperative ECD)/preoperative ECD) *100%. Compared with ECD and ECL, ECL% appears to be less affected by interference factors. For example, Al-Mohtaseb [28] reported that baseline ECD in the FLACS group (2,408.78 ± 169.73) was significantly lower than that of the CPS group (2,486.29 ± 154.37, P = 0.03). Postoperatively, there was no difference in ECD between the two groups (FLACS: 2,254.84 ± 264.46, CPS: 2,255.53 ± 262.93, P = 0.49). However, ECL% favored the FLACS group (P = 0.04). Although the postoperative ECD was the same, there were differences in the number of endothelial cells loss between the two groups; thus, the ECD may not be an accurate reflection of endothelial cell change. The same is true for ECL, where the same number of ECL accounts for different ratios when the two groups are at different baselines [42]. Given these conditions, ECL% might be a more objective indicator to represent endothelial cell changes because the preoperative variance in ECD was removed.

In addition, different surgical approaches, such as manual or femtosecond-assist corneal incision, can also influence the endothelium. Femtosecond incision was thought to cause further damage to the cornea [74]. Femtosecond laser acts on the capsular bag when pretreating cataracts. While in the step of laser-assisted corneal incision, the laser energy directly conveys to the corneal endothelium [26]. Furthermore, microbubbles arising from laser-induced corneal rupture can influence the surface tension of endothelium and amplify the damage to it [75]. However, some studies lacked a description of this step; thus, it was difficult for us to perform a subgroup analysis of corneal incisions.

Across all time points, ECD at 3 months after surgery differed from the others. We noticed studies that recorded corneal data only at 3 months after surgery [60, 67], which might exert a large impact on the 3 months postoperative outcomes of ECD. Although the ECD in the FLACS group was significantly higher than that in the CPS group, the difference disappeared when only RCTs were included (S4 Fig). Meanwhile, the heterogeneity in the RCT subgroup decreased significantly (I2 = 4%). RCT studies reduce bias due to randomized grouping and are considered more reliable than cohort studies. We, therefore, supposed that the subgroup results of the RCT were more convincing at this time point. At other time points, there was no significant difference in ECD between the two groups when considering the RCT studies only (S4 Fig).

CCT represents the degree of corneal edema and is also an evaluation index of corneal endothelial function [76]. Our study demonstrated no significant difference in CCT 1–3 days after FLACS and CPS, which indicated similar corneal edema caused by two types of cataract surgery. This was in contrast to earlier meta-analyses. However, we performed a subgroup analysis of the femtosecond platform and found that in studies using the Catalys (Johnson & Johnson Vision Care, Inc.) femtosecond platform, CCT was significantly smaller in the FLACS group (S5 Fig). It may be caused by different docking modes. In Catalys femtosecond platform, a liquid optical immersion interface (LOI) [77] is applied to the docking phase. Correspondingly, LenSx platforms use curved contact lens interface [78]. Since LOI does not directly compress the cornea, it exerts less pressure, and consequently, induces less damage to the shape of the cornea [79]. Because of the fact above, we supposed Catalys performs a better protective effect on corneal endothelium since there is no direct contact with the cornea during the femtosecond-laser period. Currently, there was no study proposing that Catalys laser platform has better endothelium protection than LenSx. And subgroup analyses of platforms at more time postoperatively had no significant results due to the limited number of studies across different platforms. We look forward to more studies on the corneal effects of femtosecond platforms in the future. CCT was significantly smaller than CPS at 1 week and 1 month in the FLACS group, while there was no significant difference at 3 months and 6 months. This implied that corneal edema resolved faster in the FLACS group, and the long-term effects of FLACS and CPS on corneal edema were similar.

CoV and 6A demonstrated that neither proved significant differences at any time point, indicating a similar morphological change of endothelial cells after surgery. Alteration in cell shape and size occurs during corneal repairment, and these two indicators represent endothelial functional capacity. It suggested that there was no difference in the effect of the two surgeries on the function of the residual endothelial cells. Interestingly, a subgroup analysis of Schroeter’s study [55] showed that CoV decreased when EPT lessened. Although the results were highly consistent, the number of studies and the follow-up time points on these two indicators were not rich enough. Therefore, more follow-up articles and subgroup analyses are necessary.

In addition, we should also note that some reports have followed up on the long-term effects of FLACS and CPS for one year. The results showed that there was no significant difference in a long-term vision, complications, and corneal effects between the two groups [36, 80]. It is worth noting that FLACS has a higher economic cost, which may also be a problem to be considered when selecting surgical methods [81].

Unavoidably, there were limitations to this meta-analysis. Firstly, the postoperative follow-up time was only 6 months, which was due to insufficient follow-up data beyond 6 months. We look forward to more long-term follow-up articles. Secondly, the included studies were from different regions, using different CPS platforms, implemented by doctors of varying proficiency, making it difficult to unify patients’ preoperative baselines, resulting in increased heterogeneity. This meta-analysis was restricted to data from published studies, so information bias could not be fully ruled out if studies with small sample-size or unpublished data exist. And we only included clinical studies published in Chinese and English, which may lead to language bias.

Conclusions

In conclusion, FLACS reduced corneal injury in the early postoperative period. Early postoperative corneal edema recovered faster than CPS. For patients with fewer endothelial cells, it is strongly recommended to consider FLACS first.

Supporting information

S1 Fig. Risk of bias graph: Based on researchers’ opinions about each risk of bias item, percentages are presented for all included studies.

(TIF)

S2 Fig. Assessment of the risk of bias in the included RCTs.

Green circle (+): Low risk, Red circle (−): High risk,?: Unclear.

(TIF)

S3 Fig. Forest plot of postoperative ECL% in general population between FLACS and CPS at A. 1–3 days, B. 1 week, C. 1 month, D. 3 months, and E. 6 months.

(TIF)

S4 Fig. Forest plot of postoperative ECD between FLACS and CPS that only included RCTs at A. 1–3 days, B. 1 week, C. 1 month, D. 3 months, and E. 6 months.

(TIF)

S5 Fig. Subgroup analysis of postoperative CCT between FLACS and CPS at 1–3 days.

(TIF)

S1 Table. The Newcastle-Ottawa Scale (NOS) of cohort studies.

(PDF)

S1 Checklist. PRISMA 2020 checklist.

(DOCX)

Data Availability

All relevant data are within the paper and its Supporting information files.

Funding Statement

This work was financially supported by the National Natural Science Foundation of China in the form of grants (82070939 and 81870641) awarded to KY. This work was also financially supported by the Key Research and Development Project of Zhejiang Province in the form of a grant (2020C03035) awarded to XC. This work was also financially supported by the Natural Science Foundation of Zhejiang Province in the form of a grant (LQ23H120005) awarded to XC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Action plan for the prevention of avoidable blindness and visual impairment, 2009–2013. World Health Organization. 2007;57:27–31. Available from: https://www.afro.who.int/publications/action-plan-prevention-avoidable-blindness-and-visual-impairment-2009-2013 [Google Scholar]
  • 2.Day AC, Gore DM, Bunce C, Evans JR. Laser-assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery. Cochrane Database Syst Rev. 2016;8;7(7):CD010735. doi: 10.1002/14651858.CD010735.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Packer M, Fishkind WJ, Fine IH, Seibel BS, Hoffman RS. The physics of phaco: a review. J Cataract Refract Surg. 2005;31(2):424–31. doi: 10.1016/j.jcrs.2004.11.027 [DOI] [PubMed] [Google Scholar]
  • 4.Nagy Z, Takacs A, Filkorn T, Sarayba M. Initial clinical evaluation of an intraocular femtosecond laser in cataract surgery. J Cataract Refract Surg. 2009;25(12):1053–1060. doi: 10.3928/1081597X-20091117-04 [DOI] [PubMed] [Google Scholar]
  • 5.Chen M, Swinney C, Chen M. Comparing the intraoperative complication rate of femtosecond laser-assisted cataract surgery to traditional phacoemulsification. Int J Ophthalmol. 2015;8(1):201–203. doi: 10.3980/j.issn.2222-3959.2015.01.34 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Mastropasqua L, Toto L, Mattei PA, Vecchiarino L, Mastropasqua A, Navarra R, et al. Optical coherence tomography and 3-dimensional confocal structured imaging system-guided femtosecond laser capsulotomy versus manual continuous curvilinear capsulorhexis. J Cataract Refract Surg. 2014;40(12):2035–2043. doi: 10.1016/j.jcrs.2014.05.032 [DOI] [PubMed] [Google Scholar]
  • 7.Mayer WJ, Klaproth OK, Hengerer FH, Kohnen T. Impact of crystalline lens opacification on effective phacoemulsification time in femtosecond laser-assisted cataract surgery. Am J Ophthalmol. 2014;157(6):1323–1234. doi: 10.1016/j.ajo.2013.09.017 [DOI] [PubMed] [Google Scholar]
  • 8.Norrby S. Sources of error in intraocular lens power calculation. J Cataract Refract Surg. 2008;34(3):368–376. doi: 10.1016/j.jcrs.2007.10.031 [DOI] [PubMed] [Google Scholar]
  • 9.Ho JW, Afshari NA. Advances in cataract surgery: preserving the corneal endothelium. Curr Opin Ophthalmol. 2015;26(1):22–27. doi: 10.1097/ICU.0000000000000121 [DOI] [PubMed] [Google Scholar]
  • 10.Sie NM, Yam GH, Soh YQ, Lovatt M, Dhaliwal D, Kocaba V, et al. Regenerative capacity of the corneal transition zone for endothelial cell therapy. Stem Cell Res Ther. 2020; 4;11(1):523. doi: 10.1186/s13287-020-02046-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Erkoc-Biradli FZ, Ozgun A, Öztürk-Öncel MÖ, Marcali M, Elbuken C, Bulut O, et al. Bioinspired hydrogel surfaces to augment corneal endothelial cell monolayer formation. J Tissue Eng Regen Med. 2021;15(3):244–255. doi: 10.1002/term.3173 [DOI] [PubMed] [Google Scholar]
  • 12.Okumura N, Koizumi N. Regeneration of the Corneal Endothelium. Curr Eye Res. 2020;45, 303–312. doi: 10.1080/02713683.2019.1700529 [DOI] [PubMed] [Google Scholar]
  • 13.Joyce NC. Proliferative capacity of corneal endothelial cells. Exp Eye Res. 2012;95:16–23. doi: 10.1016/j.exer.2011.08.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Sugar J, Mitchelson J, Kraff M. The effect of phacoemulsification on corneal endothelial cell density. Arch Ophthalmol1978;96:446–448. doi: 10.1001/archopht.1978.03910050222005 [DOI] [PubMed] [Google Scholar]
  • 15.Mencucci R, Ponchietti C, Virgili G, Giansanti F, Menchini U. Corneal endothelial damage after cataract surgery: Microincision versus standard technique. J Cataract Refract Surg. 2006;32: 1351–1354. doi: 10.1016/j.jcrs.2006.02.070 [DOI] [PubMed] [Google Scholar]
  • 16.Chen X, Ji Y, Lu Y. Comparison of clear corneal incision injuries between torsional and conventional phacoemulsification. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2013;251(9):2147–2154. doi: 10.1007/s00417-013-2423-3 [DOI] [PubMed] [Google Scholar]
  • 17.Hayashi K, Hayashi H, Nakao F, Hayashi F. Risk factors for corneal endothelial injury during phacoemulsification. J Cataract Refract Surg. 1996;22(8):1079–1084. doi: 10.1016/s0886-3350(96)80121-0 [DOI] [PubMed] [Google Scholar]
  • 18.Davison JA. Endothelial cell loss during the transition from nucleus expression to posterior chamber-iris plane phacoemulsification. J Am Intraocul Implant Soc. 1984;10(1):40–43. doi: 10.1016/s0146-2776(84)80075-0 [DOI] [PubMed] [Google Scholar]
  • 19.Walkow T, Anders N, Klebe S. Endothelial cell loss after phacoemulsification: relation to preoperative and intraoperative parameters. J Cataract Refract Surg. 2000;26(5):727–32. doi: 10.1016/s0886-3350(99)00462-9 [DOI] [PubMed] [Google Scholar]
  • 20.Kolb CM, Shajari M, Mathys L, Herrmann E, Petermann K, Mayer WJ, et al. Comparison of femtosecond laser-assisted cataract surgery and conventional cataract surgery: a meta-analysis and systematic review. J Cataract Refract Surg. 2020;46(8):1075–1085. doi: 10.1097/j.jcrs.0000000000000228 [DOI] [PubMed] [Google Scholar]
  • 21.Chen L, Hu C, Lin X, Li HY, Du Y, Yao YH, et al. Clinical outcomes and complications between FLACS and conventional phacoemulsification cataract surgery: a PRISMA-compliant Meta-analysis of 25 randomized controlled trials. Int J Ophthalmol. 2021;14(7):1081–1091. doi: 10.18240/ijo.2021.07.18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Chen X, Chen K, He J, Yao K. Comparing the Curative Effects between Femtosecond Laser-Assisted Cataract Surgery and Conventional Phacoemulsification Surgery: A Meta-Analysis. PLoS One. 2016;11(3):e0152088. doi: 10.1371/journal.pone.0152088 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. European journal of epidemiology. 2010;25(9):603–605. doi: 10.1007/s10654-010-9491-z [DOI] [PubMed] [Google Scholar]
  • 24.Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. ; Cochrane Statistical Methods Group. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011; 18;343:d5928. doi: 10.1136/bmj.d5928 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785–1805. doi: 10.1177/0962280216669183 [DOI] [PubMed] [Google Scholar]
  • 26.Abell RG, Kerr NM, Howie AR, Mustaffa Kamal MA, Allen PL, Vote BJ. Effect of femtosecond laser-assisted cataract surgery on the corneal endothelium. J Cataract Refract Surg. 2014;40(11):1777–1783. doi: 10.1016/j.jcrs.2014.05.031 Epub 2014 Sep 10. [DOI] [PubMed] [Google Scholar]
  • 27.Abell RG, Kerr NM, Vote BJ. Toward zero effective phacoemulsification time using femtosecond laser pretreatment. Ophthalmology. 2013;120(5):942–8. doi: 10.1016/j.ophtha.2012.11.045 [DOI] [PubMed] [Google Scholar]
  • 28.Al-Mohtaseb Z, He X, Yesilirmak N, Waren D, Donaldson KE. Comparison of Corneal Endothelial Cell Loss Between Two Femtosecond Laser Platforms and Standard Phacoemulsification. J Refract Surg. 2017;33(10):708–712. doi: 10.3928/1081597X-20170731-01 [DOI] [PubMed] [Google Scholar]
  • 29.Bascaran L, Alberdi T, Martinez-Soroa I, Sarasqueta C, Mendicute J. Differences in energy and corneal endothelium between femtosecond laser-assisted and conventional cataract surgeries: prospective, intraindividual, randomized controlled trial. Int J Ophthalmol. 2018;11(8):1308–1316. doi: 10.18240/ijo.2018.08.10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Cavallini GM, Fornasari E, De Maria M, Lazzerini A, Campi L, Verdina T. Bimanual femtosecond laser-assisted cataract surgery compared to standard bimanual phacoemulsification: A case-control study. Eur J Ophthalmol. 2019;29(6):629–635. doi: 10.1177/1120672118805323 [DOI] [PubMed] [Google Scholar]
  • 31.Chee SP, Yang Y, Wong MHY. Randomized Controlled Trial Comparing Femtosecond Laser-Assisted with Conventional Phacoemulsification on Dense Cataracts. Am J Ophthalmol. 2021;229:1–7. doi: 10.1016/j.ajo.2020.12.024 [DOI] [PubMed] [Google Scholar]
  • 32.Chen X, Yu Y, Song X, Zhu Y, Wang W, Yao K. Clinical outcomes of femtosecond laser-assisted cataract surgery versus conventional phacoemulsification surgery for hard nuclear cataracts. J Cataract Refract Surg. 2017;43(4):486–491. doi: 10.1016/j.jcrs.2017.01.010 [DOI] [PubMed] [Google Scholar]
  • 33.Chlasta-Twardzik E, Nowińska A, Wylęgała E. Comparison of the selected parameters of the anterior segment of the eye between femtosecond laser-assisted cataract surgery, microincision cataract surgery, and conventional phacoemulsification: A case-control study. Medicine (Baltimore). 2019;98(52):e18340. doi: 10.1097/MD.0000000000018340 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Conrad-Hengerer I, Al Juburi M, Schultz T, Hengerer FH, Dick HB. Corneal endothelial cell loss and corneal thickness in conventional compared with femtosecond laser-assisted cataract surgery: three-month follow-up. J Cataract Refract Surg. 2013;39(9):1307–13. doi: 10.1016/j.jcrs.2013.05.033 [DOI] [PubMed] [Google Scholar]
  • 35.Day AC, Burr JM, Bennett K, Bunce C, Doré CJ, Rubin GS, et al. Femtosecond Laser-Assisted Cataract Surgery Versus Phacoemulsification Cataract Surgery (FACT): A Randomized Noninferiority Trial. Ophthalmology. 2020;127(8):1012–1019. doi: 10.1016/j.ophtha.2020.02.028 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Day AC, Burr JM, Bennett K, Doré CJ, Bunce C, Hunter R, et al. Femtosecond laser-assisted cataract surgery compared with phacoemulsification cataract surgery: randomized noninferiority trial with 1-year outcomes. J Cataract Refract Surg. 2020;46(10):1360–1367. doi: 10.1097/j.jcrs.0000000000000257 [DOI] [PubMed] [Google Scholar]
  • 37.Day AC, Burr JM, Bennett K, Hunter R, Bunce C, Doré CJ, et al. Femtosecond laser-assisted cataract surgery compared with phacoemulsification: the FACT non-inferiority RCT. Health Technol Assess. 2021;25(6):1–68. doi: 10.3310/hta25060 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Dzhaber D, Mustafa O, Alsaleh F, Mihailovic A, Daoud YJ. Comparison of changes in corneal endothelial cell density and central corneal thickness between conventional and femtosecond laser-assisted cataract surgery: a randomised, controlled clinical trial. Br J Ophthalmol. 2020;104(2):225–229. doi: 10.1136/bjophthalmol-2018-313723 [DOI] [PubMed] [Google Scholar]
  • 39.Fan W, Yan H, Zhang G. Femtosecond laser-assisted cataract surgery in Fuchs endothelial corneal dystrophy: Long-term outcomes. J Cataract Refract Surg. 2018;44(7):864–870. doi: 10.1016/j.jcrs.2018.05.007 [DOI] [PubMed] [Google Scholar]
  • 40.Hansen B, Blomquist PH, Ririe P, Pouly S, Nguyen C, Petroll WM, et al. Outcomes of resident-performed laser-assisted vs traditional phacoemulsification. J Cataract Refract Surg. 2020;46(9):1273–1277. doi: 10.1097/j.jcrs.0000000000000253 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Kanellopoulos AJ, Asimellis G. Standard manual capsulorhexis / Ultrasound phacoemulsification compared to femtosecond laser-assisted capsulorhexis and lens fragmentation in clear cornea small incision cataract surgery. Eye Vis (Lond). 2016;3:20. doi: 10.1186/s40662-016-0050-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Kelkar J, Kelkar A, Pandit A, Kelkar S. A prospective comparative study on endothelial cell loss and morphology after femtolaser-assisted cataract surgery and phacoemulsification. Int Ophthalmol. 2020;40(5):1299–1305. doi: 10.1007/s10792-020-01297-5 [DOI] [PubMed] [Google Scholar]
  • 43.Khan MS, Habib A, Ishaq M, Yaqub MA. Effect of Femtosecond Laser-Assisted Cataract Surgery (FLACS) on Endothelial Cell Count. J Coll Physicians Surg Pak. 2017;27(12):763–766. . [PubMed] [Google Scholar]
  • 44.Krarup T, Ejstrup R, Mortensen A, la Cour M, Holm LM. Comparison of refractive predictability and endothelial cell loss in femtosecond laser-assisted cataract surgery and conventional phaco surgery: prospective randomised trial with 6 months of follow-up. BMJ Open Ophthalmol. 2019;4(1):e000233. doi: 10.1136/bmjophth-2018-000233 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Krarup T, Holm LM, la Cour M, Kjaerbo H. Endothelial cell loss and refractive predictability in femtosecond laser-assisted cataract surgery compared with conventional cataract surgery. Acta Ophthalmol. 2014;92(7):617–22. doi: 10.1111/aos.12406 [DOI] [PubMed] [Google Scholar]
  • 46.Krarup T, Rose K, Mensah AMA, la Cour M, Holm LM. Comparing corneal outcome between femtosecond laser-assisted cataract surgery and conventional phaco surgery in Fuchs’ endothelial dystrophy patients: a randomized pilot study with 6mo follow up. Int J Ophthalmol. 2021;14(5):684–692. doi: 10.18240/ijo.2021.05.07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Mencucci R, De Vitto C, Cennamo M, Vignapiano R, Buzzi M, Favuzza E. Femtosecond laser-assisted cataract surgery in eyes with shallow anterior chamber depth: comparison with conventional phacoemulsification. J Cataract Refract Surg. 2020;46(12):1604–1610. doi: 10.1097/j.jcrs.0000000000000341 [DOI] [PubMed] [Google Scholar]
  • 48.Mursch-Edlmayr AS, Bolz M, Luft N, Ring M, Kreutzer T, Ortner C, et al. Intraindividual comparison between femtosecond laser-assisted and conventional cataract surgery. J Cataract Refract Surg. 2017;43(2):215–222. doi: 10.1016/j.jcrs.2016.11.046 [DOI] [PubMed] [Google Scholar]
  • 49.Oka Y, Sasaki N, Injev VP. Comparison of Femtosecond Laser-Assisted Cataract Surgery and Conventional Phacoemulsification on Endothelial Cell Density When Using Torsional Modality. Clin Ophthalmol. 2021;15:4227–4237. doi: 10.2147/OPTH.S329935 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Pisciotta A, De Maria M, Verdina T, Fornasari E, de Pol A, Cavallini GM. Anterior Capsule of the Lens: Comparison of Morphological Properties and Apoptosis Induction following FLACS and Standard Phacoemulsification Surgery. Biomed Res Int. 2018;2018:7242837. doi: 10.1155/2018/7242837 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Ranjini H, Murthy PR, Murthy GJ, Murthy VR. Femtosecond laser-assisted cataract surgery versus 2.2 mm clear corneal phacoemulsification. Indian J Ophthalmol. 2017;65(10):942–948. doi: 10.4103/ijo.IJO_152_17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Reddy JC, Devta S, Vupparaboina KK, Ali MH, Vaddavalli PK. Early results of circularity and centration of capsulotomy prepared by three different methods. Int J Ophthalmol. 2021;14(1):76–82. doi: 10.18240/ijo.2021.01.11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Roberts HW, Wagh VK, Sullivan DL, Hidzheva P, Detesan DI, Heemraz BS, et al. A randomized controlled trial comparing femtosecond laser-assisted cataract surgery versus conventional phacoemulsification surgery. J Cataract Refract Surg. 2019;45(1):11–20. doi: 10.1016/j.jcrs.2018.08.033 [DOI] [PubMed] [Google Scholar]
  • 54.Schargus M, Suckert N, Schultz T, Kakkassery V, Dick HB. Femtosecond laser-assisted cataract surgery without OVD: a prospective intraindividual comparison. J Refract Surg. 2015;31(3):146–52. doi: 10.3928/1081597X-20150220-01 [DOI] [PubMed] [Google Scholar]
  • 55.Schroeter A, Kropp M, Cvejic Z, Thumann G, Pajic B. Comparison of Femtosecond Laser-Assisted and Ultrasound-Assisted Cataract Surgery with Focus on Endothelial Analysis. Sensors (Basel). 2021;21(3):996. doi: 10.3390/s21030996 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Takács AI, Kovács I, Miháltz K, Filkorn T, Knorz MC, Nagy ZZ. Central corneal volume and endothelial cell count following femtosecond laser-assisted refractive cataract surgery compared to conventional phacoemulsification. J Refract Surg. 2012;28(6):387–91. doi: 10.3928/1081597X-20120508-02 [DOI] [PubMed] [Google Scholar]
  • 57.Vasavada VA, Vasavada S, Vasavada AR, Vasavada V, Srivastava S. Comparative evaluation of femtosecond laser-assisted cataract surgery and conventional phacoemulsification in eyes with a shallow anterior chamber. J Cataract Refract Surg. 2019;45(5):547–552. doi: 10.1016/j.jcrs.2018.11.037 [DOI] [PubMed] [Google Scholar]
  • 58.Yu AY, Ni LY, Wang QM, Huang F, Zhu SQ, Zheng LY, et al. Preliminary clinical investigation of cataract surgery with a noncontact femtosecond laser system. Lasers Surg Med. 2015;47(9):698–703. doi: 10.1002/lsm.22405 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Yu Y, Chen X, Hua H, Wu M, Lai K, Yao K. Comparative outcomes of femtosecond laser-assisted cataract surgery and manual phacoemusification: a six-month follow-up. Clin Exp Ophthalmol. 2016;44(6):472–80. doi: 10.1111/ceo.12695 [DOI] [PubMed] [Google Scholar]
  • 60.Duan L, Wang LH. Postoperative curative effect and safety analysis of combined femtosecond laser and phacoemulsification for cataract patients. Biomedical Research. 2017;28 (12): 5265–5268. [Google Scholar]
  • 61.Gao QS, Di X, He W. Clinical application of femtosecond laser assisted cataract surgery combined with triple-focus intraocular lens implantation in the treatment of cataract. International Eye Science. 2018;18:491–494. doi: 10.3980/j.issn.1672-5123.2018.01.30 [DOI] [Google Scholar]
  • 62.Liu M, Zeng G, Cheng ZX. Effects of femtosecond laser assisted cataract surgery and the prognosis of patients. International Eye Science. 2016;16,1557–1560. doi: 10.3980/j.issn.1672-5123.2016.8.42 [DOI] [Google Scholar]
  • 63.Liu YC, Setiawan M, Chin JY, Wu B, Ong HS, Lamoureux E, et al. Randomized Controlled Trial Comparing 1-Year Outcomes of Low-Energy Femtosecond Laser-Assisted Cataract Surgery versus Conventional Phacoemulsification. Front Med. 2021;8:811093. doi: 10.3389/fmed.2021.811093 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Niu J. Effects of femtosecond laser-assisted cataract surgery on corneal astigmatism and SIA in patients with age-related cataract. International Eye Science. 2018;18:1838–1842, doi: 10.3980/j.issn.1672-5123.2018.10.19 [DOI] [Google Scholar]
  • 65.Shi L, Yuan Y. Femtosecond laser-assisted cataract surgery vs traditional phacoemulsification in the treatment of patients with different axial length cataracts. International Eye Science. 2020;20: 656–659, doi: 10.3980/j.issn.1672-5123.2020.4.17 [DOI] [Google Scholar]
  • 66.Wu SG, Song Q, Zhao HP, Lu LD. Effect of phacoemulsification assisted with femtosecond laser on corneal endothelial cells in patients with cataract. International Eye Science. 2017;17:749–751. doi: 10.3980/j.issn.1672-5123.2017.4.42 [DOI] [Google Scholar]
  • 67.Yang B, Yuan FL, Sun Y, Zhang J, Xu L. Femtosecond laser-assisted phacoemulsification combined with multifocal intraocular lens implantation in the treatment of cataract. International Eye Science. 2019;19:1528–1531. doi: 10.3980/j.issn.1672-5123.2019.9.19 [DOI] [Google Scholar]
  • 68.Crema AS, Walsh A, Yamane Y, Nosé W. Comparative study of coaxial phacoemulsification and microincision cataract surgery. One-year follow-up. J Cataract Refract Surg. 2007;33(6):1014–8. doi: 10.1016/j.jcrs.2007.02.035 [DOI] [PubMed] [Google Scholar]
  • 69.Zetterström C, Laurell CG. Comparison of endothelial cell loss and phacoemulsification energy during endocapsular phacoemulsification surgery. J Cataract Refract Surg. 1995; 21(1):55–8. doi: 10.1016/s0886-3350(13)80480-4 [DOI] [PubMed] [Google Scholar]
  • 70.Hayashi K, Nakao F, Hayashi F. Corneal endothelial cell loss following phacoemulsification using the Small-Port Phaco. Ophthalmic Surg. 1994;25(8):510–3. . [PubMed] [Google Scholar]
  • 71.Oshika T, Bissen-Miyajima H, Fujita Y, Hayashi K, Mano T, Miyata K, et al. Prospective randomized comparison of DisCoVisc and Healon5 in phacoemulsification and intraocular lens implantation. Eye (Lond). 2010;24(8):1376–81. doi: 10.1038/eye.2010.47 [DOI] [PubMed] [Google Scholar]
  • 72.Van den Bogerd B, Dhubhghaill SN, Koppen C, Tassignon MJ, Zakaria N. A review of the evidence for in vivo corneal endothelial regeneration. Surv Ophthalmol. 2018;63(2):149–165. doi: 10.1016/j.survophthal.2017.07.004 [DOI] [PubMed] [Google Scholar]
  • 73.Elhalis H, Azizi B, Jurkunas UV. Fuchs endothelial corneal dystrophy. Ocul Surf. 2010;8(4):173–84. doi: 10.1016/s1542-0124(12)70232-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Dzhaber D, Mustafa O, Alsaleh F, Mihailovic A, Daoud YJ. Comparison of changes in corneal endothelial cell density and central corneal thickness between conventional and femtosecond laser-assisted cataract surgery: a randomised, controlled clinical trial. Br J Ophthalmol. 2020;104(2):225–229. doi: 10.1136/bjophthalmol-2018-313723 [DOI] [PubMed] [Google Scholar]
  • 75.Kim EK, Cristol SM, Geroski DH, McCarey BE, Edelhauser HF. Corneal endothelial damage by air bubbles during phacoemulsification. Arch Ophthalmol. 1997;115(1):81–8. doi: 10.1001/archopht.1997.01100150083014 [DOI] [PubMed] [Google Scholar]
  • 76.Ventura AC, Wälti R, Böhnke M. Corneal thickness and endothelial density before and after cataract surgery. Br J Ophthalmol. 2001;85(1):18–20. doi: 10.1136/bjo.85.1.18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Talamo JH, Gooding P, Angeley D, Culbertson WW, Schuele G, Andersen D, et al. Optical patient interface in femtosecond laser-assisted cataract surgery: contact corneal applanation versus liquid immersion. J Cataract Refract Surg. 2013;39(4):501–10. doi: 10.1016/j.jcrs.2013.01.021 [DOI] [PubMed] [Google Scholar]
  • 78.Roberts TV, Lawless M, Sutton G, Hodge C. Update and clinical utility of the LenSx femtosecond laser in cataract surgery. Clin Ophthalmol. 2016;10:2021–2029. doi: 10.2147/OPTH.S94306 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Darian-Smith E, Howie AR, Abell RG, Kerr N, Allen PL, Vote BJ, et al. Intraocular pressure during femtosecond laser pretreatment: comparison of glaucomatous eyes and nonglaucomatous eyes. J Cataract Refract Surg. 2015;41(2):272–7. doi: 10.1016/j.jcrs.2014.10.026 [DOI] [PubMed] [Google Scholar]
  • 80.Stanojcic N, Roberts HW, Wagh VK, Li JO, Naderi K, O’Brart DP. A randomised controlled trial comparing femtosecond laser-assisted cataract surgery versus conventional phacoemulsification surgery: 12-month results. Br J Ophthalmol. 2021;105(5):631–638. doi: 10.1136/bjophthalmol-2020-316311 [DOI] [PubMed] [Google Scholar]
  • 81.Schweitzer C, Brezin A, Cochener B, Monnet D, Germain C, Roseng S, et al. Femtosecond laser-assisted versus phacoemulsification cataract surgery (FEMCAT): a multicentre participant-masked randomised superiority and cost-effectiveness trial. Lancet. 2020;395(10219):212–224. doi: 10.1016/S0140-6736(19)32481-X [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1 Fig. Risk of bias graph: Based on researchers’ opinions about each risk of bias item, percentages are presented for all included studies.

(TIF)

S2 Fig. Assessment of the risk of bias in the included RCTs.

Green circle (+): Low risk, Red circle (−): High risk,?: Unclear.

(TIF)

S3 Fig. Forest plot of postoperative ECL% in general population between FLACS and CPS at A. 1–3 days, B. 1 week, C. 1 month, D. 3 months, and E. 6 months.

(TIF)

S4 Fig. Forest plot of postoperative ECD between FLACS and CPS that only included RCTs at A. 1–3 days, B. 1 week, C. 1 month, D. 3 months, and E. 6 months.

(TIF)

S5 Fig. Subgroup analysis of postoperative CCT between FLACS and CPS at 1–3 days.

(TIF)

S1 Table. The Newcastle-Ottawa Scale (NOS) of cohort studies.

(PDF)

S1 Checklist. PRISMA 2020 checklist.

(DOCX)

Data Availability Statement

All relevant data are within the paper and its Supporting information files.


Articles from PLOS ONE are provided here courtesy of PLOS

RESOURCES